Polycystic ovarian syndrome-current pharmacotherapy and clinical implications
Rumaisa Rashid(University of Kashmir), Ghulam Nabi Bader(University of Kashmir), Suhail Ahmad Mir(Khalifa University of Science and Technology), Ozaifa Kareem(University of Kashmir), Fiza Amin(Government Medical College), Rifat Ara(Sher-i-Kashmir Institute of Medical Sciences), Tabassum Ali(University of Kashmir), Anjum Malik(Sher-i-Kashmir Institute of Medical Sciences)
Cited by 142
Related Papers
Flavonoids as promising molecules in the cancer therapy: An insight
|Current Research in Pharmacology and Drug Discovery|2023|120
Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
|Molecules|2022|56
Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer
|Pharmaceuticals|2023|34